跳至主要内容
临床试验/NCT05106569
NCT05106569Enrolling By Invitation不适用

Home-Based Spirometry Through Telemedicine in Amyotrophic Lateral Sclerosis (ALS)

State University of New York - Upstate Medical University2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年4月28日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
100
试验地点
2
主要终点
Change from baseline Dyspnea in Amyotrophic Lateral Sclerosis 15 (DALS-15)

研究概览

简要总结

The investigators seek to validate Slow Vital Capacity (SVC) measurement in seated and supine positions using conventional and portable spirometry.

详细描述

SVC is obtained with in-clinic conventional spirometry, in-clinic portable spirometry, and in-home portable spirometry with respiratory therapist-supervised remote pulmonary function testing every two weeks in a six month prospective study of participants with a diagnosis of Amyotrophic Lateral Sclerosis. SVC decline over time, seated and supine, will be tracked with assessments for treatment changes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of ALS as Clinically Possible, Clinically Probable, Laboratory-supported Probable and Clinically Definite ALS
  • 18 years old to 100 years old, English-speaking ALS subjects, male and female

排除标准

  • Use of non-invasive ventilation more than 16 hours daily
  • Non-English Speaker
  • Psychosis or severe mental illness
  • Use of high-dose sedating psychotropic medications determined to potentially interfere with task performance
  • Infection Control issues and specific Pulmonary, Cardiac, Vascular contraindications as listed in the Standardization of Spirometry 2019 Update (Graham 2019)

结局指标

主要结局

Change from baseline Dyspnea in Amyotrophic Lateral Sclerosis 15 (DALS-15)

时间窗: 2 week intervals for 6 months

Minimum 0, Maximum 30; Higher scores worse

Change from baseline Hospital Anxiety and Depression Scale (HADS)

时间窗: 6 months

Minimum 0, Maximum 42; Higher scores worse

Change from baseline Amyotrophic Lateral Sclerosis Assessment Questionnaire-5 (ALSAQ-5) at 6 months

时间窗: 6 months

Minimum 0, Maximum 20; Higher scores worse

Change from baseline in ALS Functional Rating Scale, Revised (ALS FRSR)

时间窗: 2 week intervals for 6 months

Minimum 0, Maximum 48; Lower scores worse

Change from baseline SVC percent predicted at clinic

时间窗: 6 months

SVC measured at clinic in seated and supine positions using conventional and portable spirometer

Change from baseline SVC percent predicted at home

时间窗: 2 week intervals for 6 months

SVC measured from home in seated and supine positions using portable spirometer

Change from baseline Amyotrophic Lateral Sclerosis Treatment Questionnaire

时间窗: 2 week intervals for 6 months

Reports usage of non-invasive ventilation, gastrostomy tube, ALS medications and ALS devices

Change from baseline Amyotrophic Lateral Sclerosis Cognitive Behavioral Screen (ALS-CBCS)

时间窗: 6 months

Minimum 0, Maximum 20; Lower scores worse

Change from baseline Amyotrophic Lateral Sclerosis Cognitive Behavioral Screen (ALS-CBCS) ALS Caregiver Behavioral Questionnaire at 6 months

时间窗: 6 months

Minimum 0, Maximum 45; Lower scores worse

次要结局

未报告次要终点

研究者

发起方
State University of New York - Upstate Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Eufrosina I. Young

Principal Investigator

State University of New York - Upstate Medical University

研究点 (2)

Loading locations...

相似试验